Sitemap
Posts
- World AMR Awareness Week 2024
- World Patient Safety Day 2024 - How the Q-POC Platform Supports Patient Safety
- A guide to the UN General Assembly High-Level Meeting on Antimicrobial Resistance 2024
- The Next Pandemic: Q-POC and Disease X
- Microarray-Based Technologies in Molecular Diagnostics: A Review
- QuantuMDx awarded Outstanding Achievement Award at Medilink Healthcare Business Awards 2024
- Regulatory Challenges in Molecular Diagnostics: An Overview
- The Benefits of Rapid Diagnostics at the Point of Care
- Great North Research Conference
- Transforming Point-of-Care Molecular Diagnostics at GIS23 Summit
- Multiplex PCR and Infectious Disease Diagnosis
- Diagnosing Influenza at the Point of Care
- The Clinical Impact of Rapid Multiplex PCR Testing Respiratory Viruses
- The Rise of Multi-Drug Resistant Gonorrhoea
- Health & Safety in laboratories
- World Immunisation Week 2023
- Point of Care Testing & the Future of Public Health
- International Day of Women and Girls in Science Day 2023
- The Relationship Between HPV and Cervical Cancer
- QuantuMDx receives CTDA approval for sale of Q-POC™
- The Role of RSV in the Burden of Respiratory Tract Infections
- World Antimicrobial Awareness Week 2022
- QuantuMDx & Menarini Announce Exclusive Distribution Agreement
- QuantuMDx & Sansure Biotech Enters into Agreement
- Combined threats of the up-and-coming flu season
- QuantuMDx announces webinar: Rising to the challenge
- QuantuMDx Shortlisted for SelectScience Clinical Scientists Awards
- Elaine Warburton OBE Wins InspiringFifty Europe 2022 Award
- QuantuMDx Special Recognition at the 2022 Med-Tech Innovation Awards
- QuantuMDx launches New PCR Respiratory Panel
- QuantuMDx wins MediLink Award 2022
- Helping Healthcare Services to Cope with Respiratory Diseases
- New Website Launch
- QuantuMDx wins two Bionow Awards 2021
- QuantuMDx Wins Made in North East Medical Life Sciences Award 2022
- SARS-CoV-2 RT-PCR Detection Assay receives CTDA legislation approval
- Martin Walton appointed as Chief Financial Officer
- Q-POC™ SARS-CoV-2 assay receives CTDA legislation approval
- What could rapid Point of Need testing mean for the future of public health?
- What are the benefits of adding LIS connectivity to a POC platform?
- Are the new COVID-19 rules a mixed blessing for care homes?
- QuantuMDx confirm its tests detect all known COVID-19 variants
- QuantuMDx investment from Vita Spring and future cooperation plans
- QuantuMDx partners with Cignpost Diagnostics
- QuantuMDx launches Q-POC™ - a PCR diagnostic system
- QuantuMDx included on PHE Microbiology Framework
- Mirre de Noo appointed as non-executive director
- QuantuMDx completes £11m funding round
- Prime Minister, Boris Johnson visits QuantuMDx
- Staff Spotlight: Andy Whittle
- Staff Spotlight: Sam Bhatt